Mark Kowalski

2016 - Arbutus Biopharma Corp

In 2016, Mark Kowalski earned a total compensation of $1.3M as Former Chief Medical Officer at Arbutus Biopharma Corp, a 33% decrease compared to previous year.

Compensation breakdown

Option Awards$246,724
Salary$378,327
Other$640,003
Total$1,265,054

Kowalski received $640K in other compensation, accounting for 51% of the total pay in 2016.

Kowalski also received $246.7K in option awards and $378.3K in salary.

Rankings

In 2016, Mark Kowalski's compensation ranked 7,117th out of 14,075 executives tracked by ExecPay. In other words, Kowalski earned more than 49.4% of executives.

ClassificationRankingPercentile
All
7,117
out of 14,075
49th
Division
Manufacturing
2,680
out of 5,486
51st
Major group
Chemicals And Allied Products
874
out of 1,900
54th
Industry group
Drugs
674
out of 1,543
56th
Industry
Pharmaceutical Preparations
534
out of 1,173
55th
Source: SEC filing on April 18, 2017.

Kowalski's colleagues

We found six more compensation records of executives who worked with Mark Kowalski at Arbutus Biopharma Corp in 2016.

2016

Mark Murray

Arbutus Biopharma Corp

Chief Executive Officer

2016

Patrick Higgins

Arbutus Biopharma Corp

Former Chief Business and Commercial Operations Officer

2016

Bruce Cousins

Arbutus Biopharma Corp

Chief Financial Officer

2016

Michael Sofia

Arbutus Biopharma Corp

Chief Scientific Officer

2016

Elizabeth Howard

Arbutus Biopharma Corp

General Counsel

2016

Peter Lutwyche

Arbutus Biopharma Corp

Chief Technology Officer

News

You may also like